Improving lives of patients with Cushing’s syndrome and adrenocortical carcinoma (ACC).
HRA Pharma Rare Diseases is dedicated to bringing the best care and services to people living with rare diseases and is committed to supporting healthcare professionals all over the world.
We have over 15 years’ experience in rare and ultra-rare diseases with a portfolio of medicines that address Cushing’s syndrome and Adrenal Cortical Carcinoma.
We are passionate about improving the lives of people affected by these conditions. We recognize that people living with rare diseases often have severe and potentially life-threatening disabilities that impact not only their quality of life, but also the lives of those who care for them. Delays in diagnosis, together with the lack of effective treatments are just some of the challenges faced by people living with a rare disease.
By partnering with the community, we are committed to tackling current challenges, reducing the time to accurate diagnosis, enabling global access to treatment and offering effective options for the long-term management of rare diseases. Our purpose is to improve quality of life and experience of care for patients. We are confident that through innovative ideas, robust science and a passionate and highly focused team, we can elevate the needs of patients living with a rare disease and help to reduce the differences in the quality of their care that exist across the globe.
Together, we make the lack of awareness around rare diseases even rarer because no patient should be left behind!